Real-world effectiveness of mood stabilizer use in schizophrenia.
Arto PuranenMarjaana KoponenMarkku LähteenvuoAntti TanskanenJari TiihonenHeidi TaipalePublished in: Acta psychiatrica Scandinavica (2022)
Mood stabilizers were relatively often used as adjunctive treatments in schizophrenia and their use was associated with a 12% decreased risk of psychosis rehospitalization, a marker of relapse in schizophrenia.